Delivery Order SPE2DB22D3301-SPE2DB24FZ3MS
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.87 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
The U.S. Defense Logistics Agency (DLA) awarded a $1,180.34 firm fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Gadavist 1 mmol/ml bulk vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $1,513.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GADAVIST 15 MMOL/15 ML VIAL 15ML, a medical commodity with a completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $1,538.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 ml vial of a 10 mmol/ml concentration medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,711.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award is a firm fixed-price delivery order for the pharmaceutical product Gadavist 1 mmol/ml bulk vial 30ml. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Gadavist, a bulk pharmaceutical product. The contract is a delivery order with a firm fixed price of $1,242.58 and an ultimate completion date of January 31, 2025. The contract is not designated as a set-aside and represents a broader indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at...
This federal contract award is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,165.20 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award date is April 1, 2024, with an ultimate completion date of April 2, 2024. This delivery order is part of a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,711.35 Delivery Order contract is for the supply of GADAVIST 1 MMOL/ML BULK VIAL 30ML, which is a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the U.S. The contract is a delivery order worth $1,711.35 for the supply of Gadavist 1 mmol/mL bulk vials. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price contract. AmerisourceBergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies for a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of the pharmaceutical product Gadavist (10 mL vial). The $1,718.64 firm fixed-price contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support...